Analyst Reco. Ensysce Biosciences, Inc.

Equities

Delayed Nasdaq Other stock markets 15:58:36 13/05/2024 BST			5-day change	1st Jan Change
0.55 ^USD	+4.96%		-2.83%	-48.11%

03-21	Transcript : Ensysce Biosciences, Inc., Q4 2023 Earnings Call, Mar 21, 2024
03-15	Ensysce Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

HC Wainwright Adjusts Ensysce Biosciences Price Target to $7 From $9, Maintains Buy Rating	25/09/23	MT
Lake Street Adjusts Price Target on Ensysce Biosciences to $8 From $80, Maintains Buy Rating	17/11/22	MT
Lake Street Initiates Coverage on Ensysce Biosciences With Buy Rating, $4 Price Target	30/11/21	MT

No results for this search